Search results (23)
« Back to NewsLudwig Oxford and IDRM host 6th form students for a taster week of research
22 July 2024
Mehdipour Public Engagement Shi Van den Eynde White
Staff and students at Ludwig Oxford and the Institute of Developmental and Regenerative Medicine put on lectures, panel sessions, lab workshops and more for 6th form students with a keen interest in scientific research.
Professor Yang Shi honoured by the Royal Society
16 May 2024
Ludwig Oxford Professor Yang Shi has been elected as a Fellow of the Royal Society for his contributions to epigenetics research
Yang Shi elected member of the National Academy of Sciences
1 May 2024
We are pleased to announce that Oxford Professor of Epigenetics Yang Shi has been elected as a member of the National Academy of Sciences in the United States.
Control of Wnt signalling by KDM5C during development impacts cognition
21 February 2024
Ludwig Oxford’s Yang Shi’s research team identifies KDM5C as a crucial sentinel for neurodevelopment.
Ludwig Oxford's Professor Yang Shi elected to Academy of Medical Sciences
18 May 2023
Ludwig Oxford's Yang Shi has been announced as a Fellow of the Academy of Medical Sciences
Ludwig Oxford Principal Investigators host interns for NDM’s summer studentships
2 May 2023
Three research teams within Ludwig Institute for Cancer Research Oxford are looking to host undergraduate and Masters students as an exciting opportunity to experience active research in an Oxford University Institute.
Two new therapeutic targets in tuft cell-like small cell lung cancer
18 October 2022
Yang Shi’s group identify two transcriptional co-activators that are selectively important for cancer cell but not normal cell survival.
Ludwig Oxford's Yang Shi elected to National Academy of Medicine
17 October 2022
Ludwig Cancer Research congratulates Yang Shi on one of the highest honours in the fields of health and medicine
Insights into the selectivity of an RNA methyltransferase
5 October 2022
Research by Professor Yang Shi and colleagues sheds light on the molecular mechanism of N6-adenosine methylation by METTL4, which may be shared by related RNA methyltransferases known to be involved in cancer.
Ludwig Oxford retreat 2022 – a recap
15 July 2022
Barnes Boccellato Byrne Constantinescu De Val Goding Kriaucionis Lu Mehdipour Moura Alves Ratcliffe Schuster-Böckler Shi Song Van den Eynde
On 13-14th June 2022, the Oxford Branch of the Ludwig Institute for Cancer Research held their annual retreat to discuss key scientific advances within the Branch and beyond.
Ludwig Oxford Member Yang Shi elected Member of the European Molecular Biology Organization
6 July 2022
Ludwig Cancer Research congratulates Yang Shi, a Member of the Oxford Branch of the Ludwig Institute for Cancer Research, on his election to the membership of the European Molecular Biology Organization (EMBO).
PhD student highly commended in competition
28 June 2022
Congratulations to Sasi Shanmugam Senga on his recognition in the Postgrad Awards run by FindAPhD
Ludwig Oxford’s Professor Yang Shi named as AACR Fellow
24 March 2022
Professor Yang Shi has been elected Fellow of the Academy of the American Association for Cancer Research (AACR), class of 2022.
Understanding the role of m6A RNA modification in transcription
25 February 2022
Research by Professor Yang Shi and colleagues suggests that METTL3-mediated RNA methylation promotes productive transcription.
Two new Ludwig Oxford professors
10 December 2021
Congratulations to Yang Shi and Stefan Constantinescu who have been successful in the 2021 University of Oxford recognition exercise.
Increasing the durability of immunotherapy
1 December 2021
Professor Yang Shi’s laboratory uncovers an important role for the chromatin regulator LSD1 in T cell exhaustion and demonstrates that LSD1 inhibition in mice increases the durability of responses to immune checkpoint blockade therapy.
The point of no return: chromatin enforces cell fate decisions
11 November 2021
Interactions between transcription factors and the chromatin environment provide barriers controlling cell differentiation, according to research by Professor Yang Shi and colleagues.
Combination treatment approach for acute myeloid leukaemia
8 June 2021
Professor Yang Shi’s group demonstrates that combining drugs targeting epigenetic and metabolic pathways can overcome the arrest of white blood cell differentiation in this blood cancer.
Ludwig-Oxford Symposium on Cancer Early Detection and Epigenetics – a recap
7 May 2021
On 28-29th April 2021, we heard the latest developments from international leaders in these fields from the University of Oxford, Ludwig Cancer Research and beyond.
Improving immunotherapy
12 March 2021
Professor Yang Shi’s group uses combination therapy to eradicate tumours that previously responded poorly to immunotherapy